C12N 2710/14042
Virus or viral particle as vehicle
Official title: virus or viral particle as vehicle, e.g. encapsulating small organic molecule
C12N2710/14042 (Virus or viral particle as vehicle) appears on 9 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 11
- Assignees
- 4
- Inventors
- 21
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 2 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 2 |
| 2023 | 1 | 1 |
| 2024 | 2 | 2 |
| 2025 | 0 | 0 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method of producing an immunogenic composition7 Jul 2026US 12,673,094 B2Boehringer Ingelheim Animal Health USA Inc.
- Recombinant viruses, insect cells and their uses in viral detection and vaccination24 Feb 2026US 12,560,607 B2Academia Sinica
- Universal influenza vaccine1 Oct 2024US 12,102,674 B2Cambridge Technologies, Inc.
- Method of producing an immunogenic composition16 Apr 2024US 11,957,746 B2
- Universal influenza vaccine3 Oct 2023US 11,771,756 B2Cambridge Technologies, Inc.
- Method of producing an immunogenic composition30 Jul 2026US 2026/0216312 A1Boehringer Ingelheim Animal Health USA Inc.
- Method of producing an immunogenic composition24 Oct 2024US 2024/0350612 A1Boehringer Ingelheim Animal Health USA Inc.
- Universal influenza vaccine21 Mar 2024US 2024/0091336 A1Cambridge Technologies, Inc.
- Recombinant viruses, insect cells and their uses in viral detection and vaccination25 May 2023US 2023/0160892 A1Academia Sinica
- Method of producing an immunogenic composition29 Dec 2022US 2022/0409715 A1Boehringer Ingelheim Animal Health USA Inc.
Most cited
By later US patents
- Vault and vault-like carrier molecules15US 7,482,319 B2The Regents of the University of California · 2009
- Vault and vault-like carrier molecules5US 8,933,203 B2The Regents of the University of California · 2015
- Vault and vault like carrier molecules5US 9,114,173 B2The Regents of the University of California · 2015
- Universal influenza vaccine2US 11,351,241 B2Cambridge Technologies, Inc. · 2022
- Universal influenza vaccine1US 11,771,756 B2Cambridge Technologies, Inc. · 2023